An Open-Label, Dose-Finding, Pharmacokinetic, Safety and Efficacy Study of Bivalirudin in Children Between 6 Months and 18 Years of Age.

Trial Profile

An Open-Label, Dose-Finding, Pharmacokinetic, Safety and Efficacy Study of Bivalirudin in Children Between 6 Months and 18 Years of Age.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jul 2016

At a glance

  • Drugs Bivalirudin (Primary)
  • Indications Deep vein thrombosis
  • Focus Therapeutic Use
  • Acronyms UNBLOCK
  • Most Recent Events

    • 27 Jun 2011 Planned end date changed from 1 Sep 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
    • 09 Sep 2009 Planned end date changed from 1 Sep 2009 to 1 Sep 2010 as reported by ClinicalTrials.gov.
    • 30 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top